RecruitingNCT06383195

The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis

The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) Physical Function Test in Enthesitis-Related Arthritis


Sponsor

Hacettepe University

Enrollment

40 participants

Start Date

Mar 21, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study assesses the test-retest reliability, construct validity, and minimal detectable change of the Ankylosing Spondylitis Performance Index (ASPI) in assessing the physical function of patients with Enthesitis-related arthritis (ERA).


Eligibility

Min Age: 7 YearsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a physical performance measurement tool called the ASPI (Ankylosing Spondylitis Performance Index) in children and teenagers with a type of juvenile arthritis called Enthesitis-Related Arthritis — a condition that causes joint inflammation, especially where tendons attach to bones. **You may be eligible if...** - You are between 7 and 18 years old - You have been diagnosed with Enthesitis-Related Arthritis by a rheumatologist - You are willing to participate voluntarily **You may NOT be eligible if...** - You have a serious heart, lung, liver, kidney, or neurological disease - You have had major bone or joint surgery - You have significant mental health difficulties that would affect participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hacettepe University

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06383195


Related Trials